Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$440,000 |
 |
Johnson & JohnsonJNJ |
-$120M |
 |
Mind Medicine (MindMed)MNMD |
-$86M |
 |
ModernaMRNA |
-$37.4B |
 |
AbbVieABBV |
-$792M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Elkins David V | Sep 2, 2025 | Sell | 56,000 | $47.33 | $2.7M |
| Short Bartie Wendy | Aug 2, 2025 | Sell | 378 | $44.23 | $17,000 |
| Hickey Benjamin | May 9, 2025 | Sell | 97 | $38.01 | $3,700 |
| Hirawat Samit | Apr 25, 2025 | Buy | 4,250 | $47.58 | $200,000 |
| BOERNER CHRISTOPHER S. | Feb 20, 2025 | Buy | 2,000 | $55.048 | $110,000 |
| Hirawat Samit | Feb 14, 2025 | Buy | 1,823 | $54.84 | $100,000 |
| Holzer Phil M | Nov 4, 2024 | Sell | 700 | $55.615 | $39,000 |
| Hirawat Samit | Nov 1, 2024 | Buy | 1,830 | $54.675 | $100,000 |
FAQ - Insider Transactions
The most recent insider transaction for Bristol-Myers Squibb was conducted by Elkins David V, who sold 56,000 shares on September 2, 2025 at a price of $47.33 per share.
Hirawat Samit has bought the most BMY stock in the last 2 years, with a total value of $400,000.
Elkins David V has sold the most BMY stock in the last 2 years, with a total value of $2.7M.
The total value of insider transactions for Bristol-Myers Squibb in the last 2 years is negative, amounting to -$2.2M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Bristol-Myers Squibb have been balanced between buying and selling, showing a neutral stance among insiders towards the company's market performance. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
